Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
M2R002
- Development stage
- Preclinical
- Lead developer
- M2RLAB
- Modality
- Cell Therapies
01
Overview
M2R002 (also known as M2R Kidney) is an autologous cell therapy being developed by M2R Lab for the treatment of acute kidney failure (AKF) and chronic kidney failure (CKF). The therapy utilizes the patient's own leukocytes, which are isolated from blood and modified using the proprietary M2R technology to adopt an anti-inflammatory and regenerative phenotype. This modification process is notable for not requiring genetic manipulation, ex vivo expansion, or the addition of exogenous growth factors. M2R002 is designed to modulate the immune response, reduce inflammation, and promote the proliferation and differentiation of endogenous stem cells to repair kidney injuries. Preclinical studies in animal models have demonstrated its potential to recover kidney function, and the candidate is currently undergoing advanced preclinical toxicity and biodistribution studies in preparation for Phase I/II clinical trials.
- Other names
- M2R KidneyM-2R KidneyM 2R Kidney
Beyond the preview
Go deeper on M2R002.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on M2R002.